The 34th Annual Roth Conference features presentations and one-on-one meetings with leading companies across a range of industries.

Register for the event here

The Edison Global Healthcare Open House returned in 2022 with a slate of leading biotech and healthcare companies.

See Tryp's presentation here

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Tryp's on-demand presentation will open on January 10, 2022 at 7:00 A.M. (ET), and
it is available for 90 days

Sign up

Biotech Showcase spans the life science ecosystem with a family of dedicated events and program sessions addressing the latest and most relevant industry opportunities and challenges.

Sign Up

CEO Greg Mckee presents an overview of the Company pipeline and upcoming clinical milestones.

Wonderland: Miami programming will span across a variety of topics surrounding the psychedelics industry and beyond.

Sign up

Features thousands of individual and institutional investors and wealth management professionals, including companies presentations followed by a 10-minute Q&A.

Featured presentations and 1on1 meetings in a virtual format with a select group of public companies in the Healthcare Life Sciences and MedTech arena.

The virtual conference featured an overview of Tryp’s business and its pipeline with Greg McKee, Chairman and CEO; Jim Gilligan, President and Chief Science Officer; and Luke Hayes, CFO.

The virtual conference featured an overview of Tryp’s business and its pipeline with Greg McKee, Chairman and CEO; Jim Gilligan, President and Chief Science Officer; and Luke Hayes, CFO.

The event included a presentation by Tryp's management team to discuss updates on its Psilocybin-for-Neuropsychiatric Disorders (PFNTM) program as well as upcoming milestones for 2021 and beyond, followed with a Q&A session.

The virtual conference featured an overview of Tryp’s business and its pipeline with Greg McKee, Chairman and CEO; Jim Gilligan, President and Chief Science Officer; and Luke Hayes, CFO.

The Psyched 21 Conference is the most comprehensive and largest psychedelics conference in the industry. Tryp Therapeutics sat down with Psyched 21 Founder, Marik Hazan.

View recording

CEO Greg Mckee presented an overview of the Company at the H.C. Wainwright Psychedelics Hybrid conference focused on Positioning for the Psychedelic Comeback in Mental Healthcare and Beyond.

The company presented at the Stifel GMP Healthcare Conference: Healthcare Psychedelics: Addressing the Global Mental Health Crisis.